Template:Percutaneous Coronary Intervention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 281: | Line 281: | ||
! | ! | ||
::[[Percutaneous coronary intervention oral antiplatelet therapy|Oral Antiplatelet Therapy]] | ::[[Percutaneous coronary intervention oral antiplatelet therapy|Oral Antiplatelet Therapy]] | ||
|- | |||
! | |||
|- bgcolor="PaleTurquoise" | |||
! | |||
::[[Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists|Glycoprotein IIb/IIIa Receptor Antagonists]] | |||
|- | |- | ||
! | ! |
Revision as of 18:01, 30 October 2012
Percutaneous Coronary Intervention Guidelines Microchapters |
CAD Revascularization: |
---|
Pre-procedural Considerations: |
Procedural Considerations: |
|
|
|
|
|
|
|
|
|
Post-Procedural Considerations: |
Quality and Performance Considerations: |
Percutaneous Coronary Intervention On the Web |
American Roentgen Ray Society Images of Percutaneous Coronary Intervention |
Directions to Hospitals Treating Percutaneous Coronary Intervention |
Risk calculators and risk factors for Percutaneous Coronary Intervention |